Campos Fernanda Carolina Alves, Mota Mariza Aparecida, Aravechia Maria Giselda, Torres Kelyan Bertani, Bub Carolina Bonet, Kutner José Mauro, Castilho Lilian
Departamento de Hemoterapia e Terapia Celular, Hospital Israelita Albert Einstein, Sao Paulo, SP, Brazil.
Hemocentro Unicamp, Campinas, SP, Brazil.
J Clin Lab Anal. 2016 Nov;30(6):845-848. doi: 10.1002/jcla.21946. Epub 2016 Apr 13.
The knowledge of D variants in patients and donors is important because anti-D alloimmunization can occur in some but not all individuals who express a variant RHD allele. Serologic distinction of RhD discrepancies is not always straightforward, which makes molecular analysis highly desirable.
A group of 223 subjects, 129 patients, and 94 blood donors was identified and analyzed on the basis of a D typing discrepancy. The D antigen expression was evaluated by tube and gel hemagglutination with four anti-D reagents. PCR-single specific primer (SSP), multiplex PCR, RHD BeadChip (Immucor), or sequencing were used for molecular analysis.
In total, 168/223 (75%) weak D and 55/223 (25%) partial D variants were identified. Hemagglutination results varied in methods and anti-D reagents used in this process. There was no standard serologic reactivity identified, which could predict what type of D variant would be identified. Among weak D samples, types 1-3 were the most common, while DAR and DVI were most prevalent among partial D samples.
Our results show that discrepancies found in the serologic typing should be investigated by molecular methods in order to determine the D variant involved and also to distinguish between weak D and partial D. The knowledge of the distribution of weak D types and partial D among populations is important for D- patients and pregnant women management.
了解患者和供体中的D变异体很重要,因为抗-D同种免疫可能发生在一些但并非所有表达变异RHD等位基因的个体中。RhD血型不符的血清学鉴别并不总是直截了当的,这使得分子分析非常必要。
基于D血型分型不符,确定并分析了一组223名受试者,其中包括129名患者和94名献血者。使用四种抗-D试剂通过试管和凝胶血凝试验评估D抗原表达。采用聚合酶链反应-单特异性引物(PCR-SSP)、多重PCR、RHD基因芯片(Immucor)或测序进行分子分析。
总共鉴定出168/223(75%)的弱D变异体和55/223(25%)的部分D变异体。在此过程中,血凝试验结果因方法和使用的抗-D试剂而异。未发现可预测将鉴定出何种类型D变异体的标准血清学反应性。在弱D样本中,1-3型最为常见,而DAR和DVI在部分D样本中最为普遍。
我们的结果表明,血清学分型中发现的不符情况应通过分子方法进行研究,以确定所涉及的D变异体,并区分弱D和部分D。了解弱D型和部分D在人群中的分布情况对于D阴性患者和孕妇的管理很重要。